Literature DB >> 1380893

Detection of allogeneic Qa/TL and Ly specificities on murine tumor cells with IgD in tumor-regressor serum.

T Tanino1, N Seo, T Okazaki, C Nakanishi-Ito, M Sekimata, K Egawa.   

Abstract

Serum from C3H/He mice, which show regression of MM2 tumor cells after transplantation and removal (regressor serum, RS) contains non-gammaglobulin components that cross-react with various tumor cells of mice [22, 23]. In addition to tumor cells, various allogeneic lymphocytes are also susceptible to an RS-dependent lymphocyte-mediated cytotoxic reaction. To identify tumor cell surface antigens that cause the cross-reactive host response, the serum components were analyzed by absorption of RS with allogeneic lymphocytes. RS components were found to recognize allogeneic lymphocyte antigens including Qa-2 and Ly6.2. Specificity for the Qa-2 antigen was further tested using Qa-2-congenic mice. The expression of Qa-2 antigen was detected on the surfaces of MM2 and other tumor cells derived from H-2k mice (seven among nine cell lines tested) by a membrane immunofluorescence method using a Qa-2-specific mAb. Physical characteristics of the Qa-2-specific component in RS were determined and found to differ from those of regular IgGs but to be similar to those of IgDs. Using an enzyme-linked immunosorbent assay with an IgD-specific mAb and Qa-2-lacZ fusion protein, the existence of IgD in RS with specificity for Qa-2 was confirmed. These results suggest that the RS component with Qa-2 specificity is an IgD, the specificity and physiological role of which are unknown.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380893     DOI: 10.1007/bf01789328

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  25 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  CYTOTOXIC TEST FOR DEMONSTRATION OF MOUSE ANTIBODY.

Authors:  E A BOYSE; L J OLD; I CHOUROULINKOV
Journal:  Methods Med Res       Date:  1964

Review 3.  Murine lymphocyte surface antigens.

Authors:  I F McKenzie; T Potter
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

4.  Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells.

Authors:  J M Zarling; H I Robins; P C Raich; F H Bach; M L Bach
Journal:  Nature       Date:  1978-07-20       Impact factor: 49.962

Review 5.  The structure and biology of human IgD.

Authors:  H L Spiegelberg
Journal:  Immunol Rev       Date:  1977       Impact factor: 12.988

6.  Regressor serum factor-dependent nonspecific killers in tumor-bearing mice.

Authors:  T Tanino; K Egawa
Journal:  Jpn J Exp Med       Date:  1986-08

7.  Cell line-specific cell surface components of hypotetraploid ascites mammary carcinoma cells inducing humoral reactions in the syngeneic host.

Authors:  T Tanino; M Saito; K Egawa
Journal:  Int J Cancer       Date:  1976-06-15       Impact factor: 7.396

8.  Structure and expression of genes encoding murine Qa-2 class I antigens.

Authors:  A L Mellor; J Antoniou; P J Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

9.  High-performance ion-exchange chromatography of plasma proteins.

Authors:  T Tomono; H Ikeda; E Tokunaga
Journal:  J Chromatogr       Date:  1983-08-26

10.  Structure and location of asparagine-linked oligosaccharides in the Fc region of A human immunoglobulin D.

Authors:  H Ishihara; S Tejima; N Takahashi; T Takayasu; T Shinoda
Journal:  Biochem Biophys Res Commun       Date:  1983-01-14       Impact factor: 3.575

View more
  4 in total

1.  Utilization of leucine methyl ester for the generation of hybridomas producing monoclonal antibodies specific to tumor-associated antigens.

Authors:  N Seo; K Egawa
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

2.  Recognition of the Qa-2k tumor antigen by T cell receptor gamma/delta of an immunopotentiator-induced tumoricidal T cell of mice.

Authors:  T Okazaki; C Nakanishi-Ito; N Seo; T Tanino; M Takiguchi; K Egawa
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

3.  Protection against metastasis by immunization with an allogeneic lymphocyte antigen.

Authors:  K Egawa; N Seo; T Tanino; T Tsukiyama
Journal:  Cancer Immunol Immunother       Date:  1995-12       Impact factor: 6.968

4.  Suppression of cytotoxic T lymphocyte activity by gamma/delta T cells in tumor-bearing mice.

Authors:  N Seo; K Egawa
Journal:  Cancer Immunol Immunother       Date:  1995-06       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.